330 related articles for article (PubMed ID: 11724293)
21. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
[TBL] [Abstract][Full Text] [Related]
22. Co-expression of Y box-binding protein-1 and P-glycoprotein as a prognostic marker for survival in epithelial ovarian cancer.
Huang X; Ushijima K; Komai K; Takemoto Y; Motoshima S; Kamura T; Kohno K
Gynecol Oncol; 2004 May; 93(2):287-91. PubMed ID: 15099935
[TBL] [Abstract][Full Text] [Related]
23. Association of nuclear YB-1 localization with lung resistance-related protein and epidermal growth factor receptor expression in lung cancer.
Hyogotani A; Ito K; Yoshida K; Izumi H; Kohno K; Amano J
Clin Lung Cancer; 2012 Sep; 13(5):375-84. PubMed ID: 22284440
[TBL] [Abstract][Full Text] [Related]
24. Multidrug resistance related genes and p53 expression in human non small cell lung cancer.
Galimberti S; Marchetti A; Buttitta F; Carnicelli V; Pellegrini S; Bevilacqua G; Petrini M
Anticancer Res; 1998; 18(4C):2973-6. PubMed ID: 9713494
[TBL] [Abstract][Full Text] [Related]
25. Topotecan-induced topoisomerase IIalpha expression increases the sensitivity of the CML cell line K562 to subsequent etoposide plus mitoxantrone treatment.
Chen S; Gomez SP; McCarley D; Mainwaring MG
Cancer Chemother Pharmacol; 2002 May; 49(5):347-55. PubMed ID: 11976828
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical detection of DNA topoisomerase IIalpha, P-glycoprotein and multidrug resistance protein (MRP) in small-cell and non-small-cell lung cancer.
Kreisholt J; Sorensen M; Jensen PB; Nielsen BS; Andersen CB; Sehested M
Br J Cancer; 1998 May; 77(9):1469-73. PubMed ID: 9652763
[TBL] [Abstract][Full Text] [Related]
27. The topoisomerase IIalpha expression correlates with survival in patients with advanced Hodgkin's lymphoma.
Provencio M; Corbacho C; Salas C; Millan I; Espana P; Bonilla F; Ramon Cajal S
Clin Cancer Res; 2003 Apr; 9(4):1406-11. PubMed ID: 12684412
[TBL] [Abstract][Full Text] [Related]
28. Nuclear expression of Y-box-binding protein-1 correlates with P-glycoprotein and topoisomerase II alpha expression, and with poor prognosis in synovial sarcoma.
Oda Y; Ohishi Y; Saito T; Hinoshita E; Uchiumi T; Kinukawa N; Iwamoto Y; Kohno K; Kuwano M; Tsuneyoshi M
J Pathol; 2003 Feb; 199(2):251-8. PubMed ID: 12533839
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of DNA topoisomerase IIalpha expression in human hepatocellular carcinoma.
Watanuki A; Ohwada S; Fukusato T; Makita F; Yamada T; Kikuchi A; Morishita Y
Anticancer Res; 2002; 22(2B):1113-9. PubMed ID: 12168909
[TBL] [Abstract][Full Text] [Related]
30. Topoisomerase I protein expression in primary colorectal cancer and lymph node metastases.
Boonsong A; Curran S; McKay JA; Cassidy J; Murray GI; McLeod HL
Hum Pathol; 2002 Nov; 33(11):1114-9. PubMed ID: 12454816
[TBL] [Abstract][Full Text] [Related]
31. [Expression and significance of DNA topoisomerase I (topo I) in small cell lung cancer].
Guo QS; Liu YX; Yu JM; Wang JL; Zhong WX; Liu XJ
Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):124-6. PubMed ID: 17645849
[TBL] [Abstract][Full Text] [Related]
32. Involvement of a DNA binding protein, MDR-NF1/YB-1, in human MDR1 gene expression by actinomycin D.
Asakuno K; Kohno K; Uchiumi T; Kubo T; Sato S; Isono M; Kuwano M
Biochem Biophys Res Commun; 1994 Mar; 199(3):1428-35. PubMed ID: 7908518
[TBL] [Abstract][Full Text] [Related]
33. [Expression of apoptosis and proliferation related genes in carcinogenesis of lung squamous cell carcinoma in rats].
Wang J; Chen HL; Zhu RQ; Diao LM; Jang M; Yang F; Liu MQ
Ai Zheng; 2003 May; 22(5):471-6. PubMed ID: 12753705
[TBL] [Abstract][Full Text] [Related]
34. DNA topoisomerase IIalpha in multiple myeloma: a marker of cell proliferation and not drug resistance.
Wilson CS; Medeiros LJ; Lai R; Butch AW; McCourty A; Kelly K; Brynes RK
Mod Pathol; 2001 Sep; 14(9):886-91. PubMed ID: 11557785
[TBL] [Abstract][Full Text] [Related]
35. Characterization of promoter elements involved in the down-regulation of topoisomerase IIalpha expression in a drug-resistant cell line.
Saxena D; Yiu GK; Ni X; Huang KC; Mantovani R; Jacquemin-Sablon AG; Ng SW
Gene; 2004 Nov; 342(1):145-55. PubMed ID: 15527974
[TBL] [Abstract][Full Text] [Related]
36. Topoisomerase IIalpha mRNA and protein expression vs. in vitro drug resistance and clinical outcome in acute leukaemia.
Uggla B; Tina E; Nahi H; Paul C; Höglund M; Sirsjö A; Tidefelt U
Int J Oncol; 2007 Jul; 31(1):153-60. PubMed ID: 17549416
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical expression of topoisomerase IIalpha (Topo IIalpha) and multidrug resistance-associated protein (MRP), plus chemosensitivity testing, as chemotherapeutic indices of ovarian and endometrial carcinomas.
Koshiyama M; Fujii H; Kinezaki M; Morita Y; Nanno H; Yoshida M
Anticancer Res; 2001; 21(4B):2925-32. PubMed ID: 11712788
[TBL] [Abstract][Full Text] [Related]
38. Direct interaction of p53 with the Y-box binding protein, YB-1: a mechanism for regulation of human gene expression.
Okamoto T; Izumi H; Imamura T; Takano H; Ise T; Uchiumi T; Kuwano M; Kohno K
Oncogene; 2000 Dec; 19(54):6194-202. PubMed ID: 11175333
[TBL] [Abstract][Full Text] [Related]
39. DNA topoisomerase I and IIalpha expression in penile carcinomas: assessing potential tumour chemosensitivity.
Berney DM; Stankiewicz E; Adlan AM; Kudahetti S; Biedrzycki OJ; Hadway P; Watkin N; Corbishley C
BJU Int; 2008 Sep; 102(8):1040-4. PubMed ID: 18489530
[TBL] [Abstract][Full Text] [Related]
40. Y-box binding protein 1 is up-regulated in proliferative breast cancer and its inhibition deregulates the cell cycle.
Yu YN; Yip GW; Tan PH; Thike AA; Matsumoto K; Tsujimoto M; Bay BH
Int J Oncol; 2010 Aug; 37(2):483-92. PubMed ID: 20596676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]